Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001758363-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,000
Total Value
$492,045.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Sale | 957 | $31.82 | $30,451.74 | 671,583 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Sale | 14,043 | $32.87 | $461,593.41 | 657,540 | Direct | โ | View Details |